09:56 AM EST - Knight Therapeutics Inc. : Announced today that its Brazilian affiliate, United Medical Ltd., is assuming full commercial activities and is relaunching AKYNZEO® (netupitant / palonosetron) in Brazil. Knight Therapeutics Inc.
shares T.GUD are trading unchanged at $5.34.